{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:12:25Z","timestamp":1788873145647,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Sepsis is an organ dysfunction caused by a dysregulated host immune response to infection. Its pronounced heterogeneity and cross-scale pathological disturbances have resulted in poorly defined core therapeutic targets and inefficient drug delivery. Artificial intelligence, with its capacity for high-dimensional data integration, can serve as a data-integrative and hypothesis-generating tool, offering new avenues for exploring potential solutions to the aforementioned bottlenecks. This review summarizes recent advances in AI-driven multi-omics-based mechanistic dissection, the use of nanodelivery systems to optimize the\n                    <jats:italic>in vivo<\/jats:italic>\n                    behavior of both biomedical and botanical drugs, and AI-assisted nanocarrier design. At the mechanistic level, AI integrates multi-omics data with graph neural networks to provide computational clues for precise molecular subtyping and the identification of potential candidate targets such as S100A8\/A9 and TREM-1. At the delivery level, nanocarriers help overcome the off-target toxicity of biomedical agents and the poor bioavailability of botanical drugs, while lesion acidification, high ROS levels, high MMP expression, and the EPR effect provide a biological basis for stimuli-responsive delivery. At the integration level, AI translates target information and microenvironmental parameters into carrier design parameters, offering computational support for material screening and response threshold optimization. A conceptual framework for an integrated \u201ctarget recognition\u2013drug matching\u2013carrier design\u2013subtype adaptation\u201d decision model is proposed, which may inform the matching of combined biomedical and botanical drug regimens with nanodelivery systems based on patient molecular subtypes. This cross-scale integration framework may offer a reference direction for research on sepsis and other heterogeneous inflammatory diseases.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1879407","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:40Z","timestamp":1788872380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence-enabled cross-scale integration of traditional Chinese medicine and biomedicine for sepsis: from mechanisms to delivery"],"prefix":"10.3389","volume":"17","author":[{"given":"Ying-ying","family":"Cai","sequence":"first","affiliation":[{"name":"Guangxi University of Chinese Medicine","place":["Nanning, China"]},{"name":"Liuzhou Traditional Chinese Medicine Hospital Affiliated to Guangxi University of Chinese Medicine","place":["Liuzhou, China"]},{"name":"Department of Emergency, Liuzhou Traditional Chinese Medicine Hospital, Liuzhou Integrated Chinese and Western Medicine Treatment Center for Snakebite","place":["Liuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Guangxi University of Chinese Medicine","place":["Nanning, China"]},{"name":"Liuzhou Traditional Chinese Medicine Hospital Affiliated to Guangxi University of Chinese Medicine","place":["Liuzhou, China"]},{"name":"Department of Emergency, Liuzhou Traditional Chinese Medicine Hospital, Liuzhou Integrated Chinese and Western Medicine Treatment Center for Snakebite","place":["Liuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, The Second Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/S41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat. Medicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"604770","DOI":"10.3389\/FMOLB.2020.604770","article-title":"Mechanistic understanding from molecular dynamics simulation in pharmaceutical research 1: drug delivery","volume":"7","author":"Alex","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e10239.1","DOI":"10.1002\/adma.202510239","article-title":"Artificial intelligence-driven nanoarchitectonics for smart targeted drug delivery","volume":"37","author":"Bae","year":"2025","journal-title":"Adv. Mater"},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/17435889.2025.2480051","article-title":"Metal-based nanoplatforms for enhancing the biomedical applications of berberine: current progress and future directions","volume":"20","author":"Baidoo","year":"2025","journal-title":"Nanomedicine Lond. Engl."},{"key":"B5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/PHARMACEUTICS15102435","article-title":"Enhancing the treatment of uncontrolled inflammation through the targeted delivery of TPCA-1-loaded nanoparticles","volume":"15","author":"Chen","year":"2023","journal-title":"Pharmaceutics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1803769","DOI":"10.3389\/fmicb.2026.1803769","article-title":"Stimuli-responsive nanocarriers for precision targeted and controlled antimicrobial drug delivery in drug-resistant infections","volume":"17","author":"Dai","year":"2026","journal-title":"Front. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"11186","DOI":"10.3390\/ijms262211186","article-title":"Integrated transcriptomic analysis of S100A8\/A9 as a key biomarker and therapeutic target in sepsis pathogenesis and AI drug repurposing","volume":"26","author":"Dave","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1039\/D1DD00024A","article-title":"Deep generative models for peptide design","volume":"1","author":"Fangping","year":"2022","journal-title":"Digit. Discov."},{"key":"B11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-2600(23)00158-3","article-title":"Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial","volume":"11","author":"Fran\u00e7ois","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"bbab159","DOI":"10.1093\/bib\/bbab159","article-title":"Utilizing graph machine learning within drug discovery and development","volume":"22","author":"Gaudelet","year":"2021","journal-title":"Brief. Bioinform."},{"key":"B13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015011645","article-title":"Nanotechnology-based photodynamic therapy: concepts, advances, and perspectives","volume":"32","author":"Garg","year":"2015","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/S41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-019-0351-1","article-title":"Exploration of the nanomedicine-design space with high-throughput screening and machine learning","volume":"3","author":"Gokay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"Grommes","year":"2011","journal-title":"Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"322274","DOI":"10.1016\/j.jconrel.2020.03.043","article-title":"Can machine learning predict drug nanocrystals?","volume":"322","author":"He","year":"2020","journal-title":"J. Control Release"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Hernando","year":"2014","journal-title":"Shock (Augusta, Ga.)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17435889.2025.2608357","article-title":"The role of immunomodulatory nano systems in the treatment of sepsis: past, present, and future","volume":"21","author":"Hossan","year":"2025","journal-title":"Nanomedicine Lond. Engl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3521048","DOI":"10.1016\/j.jconrel.2022.11.013","article-title":"Stimuli-responsive and biomimetic delivery systems for sepsis and related complications","volume":"352","author":"Ismail","year":"2022","journal-title":"J. Control. Release Official J. Control. Release Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","article-title":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis","volume":"10","author":"Karakike","year":"2019","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","article-title":"The artificial intelligence clinician learns optimal treatment strategies for sepsis in intensive care","volume":"24","author":"Komorowski","year":"2018","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/S41590-023-01490-5","article-title":"Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis","volume":"24","author":"Kwok","year":"2023","journal-title":"Nat. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/S12951-026-04362-W","article-title":"A multifunctional ICAM1-directed MnO2@ZIF8 nanoplatform with Tanshinone IIA synergistically reverses senescence and restores alveolar regeneration in septic lung injury","volume":"24","author":"Lin","year":"2026","journal-title":"J. Nanobiotechnology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/D41586-023-02896-9","article-title":"AI can help to speed up drug discovery \u2014 but only if we give it the right data","volume":"621","author":"Marissa","year":"2023","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"s66","DOI":"10.7861\/clinmedicine.16-6-s66","article-title":"Acute respiratory distress syndrome","volume":"16","author":"Mason","year":"2016","journal-title":"Clin. Med. (Lond)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/nejmra2403213","article-title":"Sepsis and septic shock","volume":"391","author":"Meyer","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.immuni.2020.11.005","article-title":"Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging","volume":"54","author":"Mogilenko","year":"2021","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater"},{"key":"B31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacological Sciences"},{"key":"B32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1097\/CM9.0000000000003703","article-title":"Advances in nanocarrier-mediated cancer therapy: progress in immunotherapy, chemotherapy, and radiotherapy","volume":"138","author":"Peng","year":"2025","journal-title":"Chin. Med. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"Alex. AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacological Sciences"},{"key":"B35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12951-023-02165-x","article-title":"Advanced application of nanotechnology in active constituents of traditional Chinese medicines","volume":"21","author":"Qiu","year":"2023","journal-title":"J. Nanobiotechnol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.apsb.2025.12.011","article-title":"Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives","volume":"16","author":"Shen","year":"2026","journal-title":"Acta Pharm. Sin. B"},{"key":"B39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.2147\/IJN.S526731","article-title":"Recent progress in nano-TCM active ingredient co-delivery systems for inflammation-mediated diseases","volume":"20","author":"Sun","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/S41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"287ra71","DOI":"10.1126\/scitranslmed.aaa5993","article-title":"A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set","volume":"7","author":"Timothy","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/J.IMMUNI.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"Tom","year":"2021","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression","volume":"84","author":"Torres","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","article-title":"Computational pharmaceutics \u2013 a new paradigm of drug delivery","volume":"338","author":"Wang","year":"2021","journal-title":"J. Control Release"},{"key":"B48","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.34133\/RESEARCH.1254","article-title":"Emerging nanomedicine strategies for sepsis: immunomodulation and beyond","volume":"9","author":"Yang","year":"2026","journal-title":"Res. (Wash D C)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.mtbio.2026.103153","article-title":"Artificial intelligence-assisted design and optimization of stimuli-responsive nanocarriers for smart drug delivery","volume":"38","author":"Yazdani","year":"2026","journal-title":"Mater Today bio."},{"key":"B51","doi-asserted-by":"publisher","first-page":"690049","DOI":"10.3389\/fgene.2021.690049","article-title":"Graph neural networks and their current applications in bioinformatics","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"611087","DOI":"10.3389\/FPHAR.2020.611087","article-title":"Tanshinone IIA: a review of its anticancer effects","volume":"11","author":"Zhong-ying","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1879407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:59:41Z","timestamp":1788872381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1879407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":52,"alternative-id":["10.3389\/fphar.2026.1879407"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1879407","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1879407"}}